Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
Background Age‐related macular degeneration (AMD) is one of the leading causes of
permanent blindness worldwide. The current mainstay of treatment for neovascular AMD …
permanent blindness worldwide. The current mainstay of treatment for neovascular AMD …